Autoantigens interact with cis-acting elements of rubella virus RNA.
Rubella virus (RV) infections in adult women can be associated with acute and chronic arthritic symptoms. In many autoimmune individuals, antibodies are found targeting endogenous proteins, called autoantigens, contained in ribonucleoprotein complexes (RNPs). In order to understand the molecular mechanisms involved in the RV-associated pathology, we investigated the nature of cellular factors binding RV RNA and whether such RNPs were recognized by antibodies in infected individuals. Previously, we noted that cellular proteins associated with the RV 5'(+) stem-loop (SL) RNA are recognized by serum with Ro reactivity. To better understand the nature of the autoantigens binding RV cis-acting elements, serum samples from individuals with various autoimmune diseases were tested for their ability to immunoprecipitate RNPs containing labeled RV RNAs. A subset of serum samples recognizing autoantigen La, or Ro and La, immunoprecipitated both the RV 5'(+)SL and 3'(+)SL RNA-protein complexes. Autoantigens binding the RV 5'(+)SL and 3'(+)SL RNAs differed in molecular mass, specificities for respective RNA binding substrates, and sensitivity to alkaline phosphatase treatment. The La autoantigen was found to interact with the RV 5'(+)SL RNA as determined by immunological techniques and binding reactions with mixtures containing recombinant La protein. To test whether there is a correlation between La binding to an RV RNA element and the appearance of an anti-La response, we measured anti-La titers in RV-infected individuals. Significant anti-La activity was detected in approximately one-third of RV-infected individuals 2 years postinfection.
Pogue
G P
GP
Laboratory of Molecular Pharmacology, Food and Drug Administration, Bethesda, Maryland 20892, USA.
Hofmann
J
J
Duncan
R
R
Best
J M
JM
Etherington
J
J
Sontheimer
R D
RD
Nakhasi
H L
HL
D000328:Adult; D000818:Animals; D000914:Antibodies, Viral; D001168:Arthritis / Q000150:complications / Q000276:immunology; D001323:Autoantibodies / Q000097:blood*; D001324:Autoantigens / Q000096:biosynthesis / Q000276:immunology*; D001327:Autoimmune Diseases / Q000097:blood / Q000276:immunology*; D001483:Base Sequence; D002522:Chlorocebus aethiops; D003001:Cloning, Molecular; D004926:Escherichia coli; D005260:Female; D006801:Humans; D008969:Molecular Sequence Data; D009690:Nucleic Acid Conformation; D009838:Oligodeoxyribonucleotides; D012367:RNA, Viral / Q000096:biosynthesis / Q000276:immunology*; D011994:Recombinant Proteins / Q000096:biosynthesis / Q000276:immunology; D012261:Ribonucleoproteins / Q000096:biosynthesis / Q000276:immunology*; D012409:Rubella / Q000150:complications / Q000276:immunology; D012412:Rubella virus / Q000235:genetics / Q000276:immunology*; D013698:Templates, Genetic; D014158:Transcription, Genetic; D014709:Vero Cells; D000097585:SS-B Antigen
D000914:Antibodies, Viral; D001323:Autoantibodies; D001324:Autoantigens; D009838:Oligodeoxyribonucleotides; D012367:RNA, Viral; D011994:Recombinant Proteins; D012261:Ribonucleoproteins; D000097585:SS-B Antigen